Ken Garber. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Alzheimer Disease/drug therapyAlzheimer Disease/metabolismAlzheimer Disease/prevention & controlAlzheimer Disease/therapyAmyloid beta-Peptides/metabolismAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedClinical Trials as Topic/methodsDrug IndustryHumans
Substances: See more » Amyloid beta-PeptidesAntibodies, MonoclonalAntibodies, Monoclonal, Humanizedcrenezumab
Year: 2012 PMID: 22871696 DOI: 10.1038/nbt0812-731
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908